Blockade of the renin-angiotensin system in small arteries and anticontractile function of perivascular adipose tissue

Journal of Hypertension

Volumn 33, Issue 5, 2015, Pages 1039-1045

  Rosei, Claudia Agabiti ^b   Withers, Sarah B ^a   Belcaid, Laila ^a   De Ciuceis, Carolina ^b   Rizzoni, Damiano ^b   Heagerty, Anthony M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Hypoxia; Microcirculation; Obesity; Small arteries; Wistar Kyoto rats

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN; RENIN; TELMISARTAN; ADIPOCYTOKINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTICLE; DIET INDUCED OBESITY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MUSCLE CONTRACTILITY; MYOGRAPHY; NONHUMAN; OBESITY; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; RAT; UPREGULATION; ADULT; ANIMAL; ANOXIA; ARTERIOLE; DISEASE MODEL; DRUG EFFECTS; FEMALE; HUMAN; MESENTERIC ARTERY; METABOLISM; OXIDATIVE STRESS; PRECLINICAL STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; VASOCONSTRICTION; WISTAR KYOTO RAT;

ADIPOKINES; ADIPOSE TISSUE; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANOXIA; ARTERIOLES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; OBESITY; OXIDATIVE STRESS; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTION;

EID: 84929239473     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000506     Document Type: Article

References (49)

1. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006; 14 (Suppl 5):242S-249S.
2. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 2002; 25:855-861.
3. Soltis EE, Cassis LA. Influence of adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A Theory Pract 1991; 13:277-296.
4. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16:1057-1063.
5. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circulat Physiol 2003; 286:H1107-H1113.
6. Gao YJ, Lu C, Su LY, Sharma AM, Lee RMKW. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide [comment]. Br J Pharmacol 2007; 151:323-331.
7. Gao Y-J, Zeng Z-H, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 2005; 130:1130-1136.
8. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, et al. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK (Ca) channels. Circulation 2003; 107:769-776.
9. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44:271-276.
10. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119:1661-1670.
11. Withers SB, Agabiti Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, Heagerty AM. Studies in CD11b-DTR macrophage deficient mice prove that macrophage activation is responsible for the loss of anticontractile function in inflamed perivascular adipose tissue. Artherioscler Thromb Vasc Biol 2011; 31:908-913.
12. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Coexpression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17:555-560.
13. Perivascular adipose tissue, local Renin-Angiotensin SystemFrom Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008; 10:93-98.
14. Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455:479-492.
15. Harte A, Mc Ternan P, Chetty R, Coppack S, Katz J, Smith S, Kumar S. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation 2005; 111:1954-1961.
16. Patten DA, Lafleur VN, Robitaille GA, Chan DA, Giaccia AJ, Richard DE. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 2010; 21:3247-3257.
17. Pagé Elisabeth L, Robitaille Genevié ve A, Pouyssé gur J, Richard DE. Induction of hypoxia-inducible factor-1a by transcriptional and translational mechanisms. J Biol Chem 2002; 277:48403-48409.
18. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
19. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43: 854-864.
20. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with not insulin dependent diabetes mellitus. Circulation 2001; 103:1238-1244.
21. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
22. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
23. Lemarié CA, Paradis P, Schiffrin EL. New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med 2008; 86:673-678.
24. Jaffe IZ, Mendelshon ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralcorticoid receptors in human coronary artery smooth muscle cells. Circ Res 2005; 96:643-650.
25. Zhang R, Wu Y, Zhao M, Liu C, Zhou L, Shen S, et al. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2009; 297:L631-L640.
26. Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 2012; 13:87-88.
27. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24:e13-e18.
28. Hall JE. The kidney, hypertension and obesity. Hypertension 2003; 41 (3 pt 2):625-633.
29. Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002; 10:1203-1206.
30. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 2007; 120 (9 Suppl 1):S10-S16; [discussion S16-S17].
31. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22:1991-1998.
32. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43:1817-1822.
33. Grassi G, Seravalle G, Scopelliti F, Dell'Oro R, Fattori L, Quarti-Trevano F, et al. Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity. Obesity (Silver Spring) 2010; 18:92-98.
34. Grassi G, Seravalle G, Brambilla G, Facchetti R, Bolla G, Mozzi E, Mancia G. Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients. J Hypertens 2010; 28:1708-1714.
35. De Ciuceis C, Porteri E, Rizzoni D, Corbellini C, La Boria E, Boari GE, et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension 2011; 58:29-36.
36. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart S. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular morality in the San Antonio Heart study. Circulation 2004; 110:1251-1257.
37. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444/7121:840-846.
38. Lolmède K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumié A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 2003; 27:1187-1195.
39. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-355.
40. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58:718-725.
41. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56:901-911.
42. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293:E1118-E1128.
43. Olli K, Lahtinen S, Rautonen N, Tiihonen K. Betaine reduces the expression of inflammatory adipokines caused by hypoxia in human adipocytes. Br J Nutr 2012; 19:1-7.
44. Schnabel R, Larson MG, Dupuis J, Lunetta KL, Lipinska I, Meigs JB, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008; 51:1651-1657.
45. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty AM. Review: Vascular remodeling implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007; 1:129-137.
46. De Ciuceis C, Rossini C, Porteri E, La Boria E, Corbellini C, Mittempergher F, et al. Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. Blood Press 2013; 22:165-172.
47. Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr 2000; 71:438-442.
48. Penna-de-Carvalho A, Graus-Nunes F, Rabelo-Andrade J, Mandarim-de- Lacerda CA, Souza-Mello V. Enhanced pan-PPAR gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan. Exp Physiol 2014; 99:1663-1678.
49. Roncal CA, Reungjui S, Sánchez-Lozada LG, Mu W, Sautin YY, Nakagawa T, Johnson RJ. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol 2009; 30:399-404.